MDM Policy & Practice is a premier open-access journal published by SAGE Publications Inc, focusing on the critical fields of Health Policy and Public Health, Environmental and Occupational Health. Since its inception in 2016, this journal has aimed to provide an authoritative platform for disseminating research findings, policy discussions, and innovative practices that drive improvements in health systems globally. With an impact factor that reflects its growing influence in the academic landscape, it holds a Q2 ranking in both Health Policy and Public Health categories as of 2023. This journal leverages its accessibility to foster a collaborative environment for researchers, policymakers, and practitioners alike, encouraging the exchange of ideas and knowledge to address pressing health challenges. Operating under a commitment to open access, MDM Policy & Practice ensures that vital research is available to a wider audience, fostering informed decision-making and progressive advancements in the health policy sphere.

PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.

REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES is a prestigious journal published by the OFFICE INTERNATIONAL DES EPIZOOTIES based in France, known globally for its commitment to advancing knowledge in the fields of Animal Science and Zoology as well as Medicine. With its ISSN 0253-1933 and E-ISSN 1608-0637, this journal has been a vital resource for researchers and practitioners since its establishment in 1990. Currently ranked in the Q3 quartile across both the Animal Science and Medicine categories in 2023, it reflects a growing impact in the veterinary community, holding commendable ranks in the veterinary general and miscellaneous categories. Although it does not offer open access options, its comprehensive articles are crucial for informing best practices, public health policies, and advancing research in veterinary medicine. With an emphasis on innovative approaches and evidence-based studies, the journal serves as a significant platform for networking and collaboration among scholars, professionals, and students dedicated to improving animal health and welfare worldwide.

Health Policy and Technology is a prestigious academic journal published by ELSEVIER SCI LTD that has established itself as a leader in the fields of Biomedical Engineering and Health Policy. With an impressive Q1 ranking in both disciplines as of 2023, the journal offers a platform for original research, reviews, and innovative technological solutions that aim to bridge the gap between health policy and technology. Since its inception in 2012, it has served as a vital resource for researchers, professionals, and students who are seeking to explore the impact of technology on healthcare systems and policies globally. Although it is not an open-access journal, the high-quality, peer-reviewed articles published within its pages contribute significantly to the discourse on the advancement of healthcare practices. The journal's commitment to disseminating groundbreaking studies ensures it remains a crucial reference point in these rapidly evolving fields.

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

BMC Medical Informatics and Decision Making is a leading journal in the fields of medical informatics and health policy, published by BMC since its inception in 2001. With an impressive impact factor reflecting its status as a Q1 journal in both Computer Science Applications and Health Informatics, it serves as a vital resource for researchers, professionals, and students dedicated to advancing healthcare through informatics. The journal is committed to disseminating high-quality, peer-reviewed research focused on the innovative use of information technology in healthcare, decision-making processes, and policy formulation. As an Open Access platform, it ensures that findings are widely accessible and can foster collaboration across various disciplines. Positioned at the cutting edge of health informatics, BMC Medical Informatics and Decision Making aims to influence practice and inspire new research directions, making it an essential publication for anyone involved in improving health systems worldwide.

JMIR Medical Informatics is a leading open access journal dedicated to the field of medical informatics, published by JMIR Publications, Inc. since 2013 in Canada. With an impressive impact factor and a distinguished Q2 ranking in both Health Informatics and Health Information Management categories, this journal plays a pivotal role in disseminating cutting-edge research and innovative practices. Covering a wide scope that includes clinical informatics, health information systems, and data analytics, JMIR Medical Informatics provides valuable insights for researchers, practitioners, and policymakers alike. The journal is accessible to a global audience, ensuring that pioneering studies and methodologies reach those who can apply them to enhance health outcomes. With its commitment to advancing the body of knowledge in medical informatics, this journal stands as a vital resource for anyone involved in or studying the intersection of healthcare and technology.

SWISS MEDICAL WEEKLY is a leading peer-reviewed journal published by the SMW supporting association, available in both print and digital formats under open access since 2001. With an ISSN of 1424-7860 and E-ISSN 1424-3997, this journal has established itself as a crucial platform for disseminating innovative research and clinical advancements in the field of Medicine. Based in Basel, Switzerland, the journal boasts an impressive Scopus ranking of #101 among 636 in the General Medicine category, placing it in the 84th percentile and categorized in the Q3 Quartile of journals for 2023. Covering a wide range of topics relevant to contemporary medical practice and research, the SWISS MEDICAL WEEKLY serves not only as a valuable resource for healthcare professionals but also as a pivotal publication for academic researchers and students alike. By providing open access to high-quality research, it encourages knowledge sharing and fosters collaboration across borders, making significant contributions to the global medical community.